Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 811 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR New Study Shows Intermittent Fasting May Reduce Breast Cancer Risk and... January 26, 2021 Rediscovered Drugs Hit Leukemia from Two Different Angles July 21, 2020 Developing Biomarkers for Immunotherapy: A Conversation with Drs. Magdalena Thurin and... July 27, 2018 ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster... February 4, 2026 Load more HOT NEWS Colorectal Cancer Screening: The Silver Lining Zilovertamab Vedotin Is Safe and Demonstrates Activity In Heavily Pretreated Patients... EMA Recommends Granting a Marketing Authorisation for Generic Abiraterone for the... Enhertu Improves Survival for Metastatic “HER2-Low” Breast Cancer
